GFR Measurement With Contrast-enhanced Dynamic MRI (IREN)

University Hospital of Bordeaux

Status: Completed

Conditions: Transplantation, Kidney; Graft Occlusion, Vascular

Treatments: Device: Contrast-enhanced dynamic MRI

Study type: Interventional

Funder types: Other

Identifiers

NCT00614081

2005-029

7825

Details and patient eligibility

About

The aim of the study is to optimize and validate this MR-based GFR measurement in patients with a renal transplant, compared with the reference method, the Cr51- EDTA method: to select the most accurate combination of post-treatment of renal MR images and then evaluate its intra- and inter-rater reliability.

Full description

Cr51- EDTA method is considered the reference method for measurement of glomerular filtration rate (GFR). However, this method requires several hours and several blood and urinary samplings. Therefore, the ability to get access to this parameter with a simple, valid and reliable method would be a significant progress in clinical follow-up of patients with renal disease. Contrast-enhanced dynamic MRI is now able to give this access to functional parameters as GFR, rapidly and non invasively, becoming an alternative to Cr51-EDTA method. If the acquisition method has been optimized, some problems remain unsolved: is the movement correction worthwhile for the accuracy of the measurement ? Which model provides the most accurate results ? What is the best way to calculate the total GFR (addition of all the voxels or the product of a mean value by the cortical volume)? These questions can be answered only by a comparison with a reference method.

The reference method will be performed after standard hydration, with intravenous injection of 100 µCi of Cr51- EDTA and urinary and blood samplings every 30 minutes during 3h. Dynamic MRI will be performed with fast 3D T1-weighted gradient-echo sequences during 5 minutes after injection of a third of a clinical dose of gadolinium. Post-treatment of images will be done on an off-line program allowing movement correction, conversion of signal intensity into concentration and application of different models. 8 combinations of post-treatment will be tested and compared to the reference method.

Enrollment: 71 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with a renal transplant presenting with a graft dysfunction or a suspicion of vascular complication (renal artery stenosis...) or of urinary complication (dilatation of excretory system, collection) justifying to perform a non urgent MR examination
• Calculated glomerular clearance (MDRD method) > 20 ml/min
• Age ≥ 18 yo at the time of inclusion
• Negative pregnancy test
• Affiliation to the Social Security
• Written informed consent signed

Exclusion criteria

• Contra-indication to MRI: neurovascular clips, pacemaker, cochlear implant, orbital metallic object, claustrophobic patients...
• Contra-indication to gadolinium: previous hypersensitivity to Gd-Chelates
• Pregnancy or breastfeeding women
• Adult under legal supervision

Trial design

71 participants in 1 patient group

1

Experimental group

Description:

Renal transplant recipients

Treatment:

Device: Contrast-enhanced dynamic MRI